IRIS
FURFARO, ELISA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.704
Totale 2.704
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 2.704
Totale 2.704
Salva come PNG Salva come JPEG
Città #
Genova 2.156
Rapallo 333
Genoa 209
Bordighera 6
Totale 2.704
Salva come PNG Salva come JPEG
Nome #
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 157
Pharmacokinetics of Lopinavir Determined with an ELISA Test in Youths with Perinatally Acquired HIV. 139
Non-cultural methods for the diagnosis of invasive fungal disease 129
Is initial serum (1,3)-β-d-glucan truly associated with mortality in patients with candidaemia? Authors' response 124
Galactomannan in piperacillin-tazobactam: how much and to what extent? 121
Invasive mycoses in children receiving hemopoietic SCT 118
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 112
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 111
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 110
Galactomannan: testing the same sample twice? 108
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 108
High levels of beta-D-glucan in immunocompromised children with proven invasive fungal disease 107
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 107
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 102
Performance of the galactomannan antigen detection test in the diagnosis of invasive aspergillosis in children with cancer or undergoing haemopoietic stem cell transplantation 102
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 95
Galactomannan testing might be useful for early diagnosis of fusariosis. 93
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 92
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 90
Aspergillus meningitis: A rare clinical manifestation of central nervous system aspergillosis. Case report and review of 92 cases. 86
Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children 85
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 76
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 75
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 70
Persistence of a positive (1,3)-beta-D-glucan test after clearance of candidemia in hematopoietic stem cell transplant recipients. 60
Case report of the reliability 1,3-β-D-glucan monitoring during treatment of peritoneal candidiasis in a child receiving continuous peritoneal dialysis 52
Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan 50
Hepatitis E Virus Infection in an Italian Cohort of Hematopoietic Stem Cell Transplantation Recipients: Seroprevalence and Infection 29
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 22
Levels of beta-D-glucan in Candida auris supernatants, an in vitro and in vivo preliminary study 15
Bloodstream infections are an improbable cause of positive serum (1,3)-β-D-glucan in hematology patients 12
The Importance of Quantitative Results of a Lateral Flow Aspergillus Assay: The Significant Impact on Specificity 2
Totale 2.759
Salva come PNG Salva come JPEG
Categoria #
all - tutte 8.118
article - articoli 8.118
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 16.236
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019146 0 0 0 0 0 0 0 0 0 0 79 67
2019/2020767 33 23 23 53 67 90 103 63 81 124 75 32
2020/2021294 15 31 12 26 15 20 18 63 18 39 14 23
2021/2022349 6 16 16 48 18 45 17 78 15 38 8 44
2022/2023396 36 40 7 43 70 69 1 25 59 5 30 11
2023/2024154 10 24 4 32 18 34 11 8 11 2 0 0
Totale 2.759